Prevention, testing and treatment of Hepatitis C and other infections

Networking zone 4 (N4)
In programme
Thursday, 24 November, 2022 - 15:00 to 16:30
View presentations

About

This session brings together a variety of short communications focused on the prevention, testing, and treatment of hepatitis C and other infections among people who inject drugs.
 

Chair

Larney
Sarah
  • Assistant Professor,
  • University Of Montreal,
  • Montreal,
  • Canada

Type

Tracks

Keywords

Presentations

Thursday, 24 November

15:00
Short communication

Educations for safer injection in the Mobile Drug Consumption Room in Lisbon

15:00 to 16:30
Networking zone 4 (N4)
Ângela Leite
Short communication

Harm reduction services in the Netherlands: recent developments and challenges.

15:00 to 16:30
Networking zone 4 (N4)
Nadine G.M. van Gelder
Short communication

Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland

15:00 to 16:30
Networking zone 4 (N4)
Claudia Bernardini
Short communication

Individual and structural factors associated with recent hepatitis C testing in people who inject drugs: gender-based analyses of the Cosinus Cohort

15:00 to 16:30
Networking zone 4 (N4)
Ilhame Anwar
Short communication

Real time surveillance on the impact of restrictions on harm reduction services to improve responsiveness and reduce harms in unprecedented times

15:00 to 16:30
Networking zone 4 (N4)
Josie Smith
Short communication

Real-world hepatitis C treatment outcomes among people who inject drugs at the Stockholm needle exchange program, Sweden

15:00 to 16:30
Networking zone 4 (N4)
Martin Kåberg
Short communication

Transactional sex as a pathway for rising sexually transmitted infections amidst the opioid epidemic in the United States

15:00 to 16:30
Networking zone 4 (N4)
Mance Buttram
View the programme